Bristol-Myers Deal Comes With Potential Bonus Payout for Celgene

(Bloomberg) -- Bristol-Myers Squibb Co.’s mega-deal for Celgene Corp. has a notable sweetener for the seller: its shareholders will get an extra $9 per share in cash if regulators green-light some ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.